0001780981-19-000001.txt : 20190723 0001780981-19-000001.hdr.sgml : 20190723 20190723125959 ACCESSION NUMBER: 0001780981-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190723 DATE AS OF CHANGE: 20190723 EFFECTIVENESS DATE: 20190723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merand Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001780981 IRS NUMBER: 825449957 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-344857 FILM NUMBER: 19967416 BUSINESS ADDRESS: STREET 1: 1878 CATLIN ROAD CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 BUSINESS PHONE: 919-308-5765 MAIL ADDRESS: STREET 1: 1878 CATLIN ROAD CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 D 1 primary_doc.xml X0708 D LIVE 0001780981 Merand Pharmaceuticals, Inc. 1878 CATLIN ROAD CHARLOTTESVILLE VA VIRGINIA 22901 1-800-829-4933 DELAWARE None None Corporation true 2018 Brian H. Annex, M.D. Merand Pharmaceuticals, Inc. 1878 Catlin Road Charlottesville VA VIRGINIA 22901 Executive Officer Director Alan I. Annex Merand Pharmaceuticals, Inc. 1878 Catlin Road Charlottesville VA VIRGINIA 22901 Executive Officer Director Promoter Vice President & Secretary Anthony Giordano Merand Pharmaceuticals, Inc. 1878 Catlin Road Charlottesville VA VIRGINIA 22901 Executive Officer Director CEO Pharmaceuticals Decline to Disclose 06b false 2019-07-12 true true true true Series A Preferred Stock; upon conversion, issuance of underlying common shares false 0 1250000 1135000 115000 false 11 0 0 0 true Certain persons named in Item 3 or affiliates thereof may receive payments deemed to be made from the proceeds of the offering, including management and administrative fees, the amounts of which cannot be estimated at this time. false Merand Pharmaceuticals, Inc. /s/ Brian H. Annex, M.D. Brian H. Annex, M.D. President & Treasurer 2019-07-21